Aims: Ovarian cancer is the principal cause of gynaecological cancer death in developed countries, yet overall survival in the UK has been reported as being inferior to that in some Western countries. As there is a range of survival across the UK we hypothesised that in major regional centres,...
Mainly ovarian cancer proceeds without any symptoms during the first stage. Besides, the first symptoms (increased stomach) are very often considered adnexitis ( inflammation of the ovaries) Tumor is gradually spread over the abdominal cavity affecting the omentum and causing fluid accumulation (ascite...
IS-44 Impact on survival rate of combination chemotherapy of carboplatin and cisplatin (JP) in stage III,IV ovarian cancer.喜欢 0 阅读量: 10 作者:Onishi,Yoshitaka,Nakamura,Toshiaki,Wada,Toshiro,Maeda,Takatugu,Hatae,Masayuki 年份: 1996 收藏 引用 批量引用 报错 分享 求助全文 通过文献互助平台发起...
Ovarian cancer is difficult to diagnose because symptoms often do not occur until late in the disease. Symptoms do not occur until the tumor has grown large enough to apply pressure to other organs in the abdomen, or until the cancer has spread to remote organs. The symptoms are nonspecific,...
Purpose: To compare the clinical characteristics and survival of Ashkenazi Jewish ovarian cancer patients with and without BRCA1 and BRCA2 mutations. Methods: An unselected series of 118 Ashkenazi Jewish ovarian cancer patients were screened for the three common founder mutations in BRCA1 and BRCA2....
Residual plots for the ovarian cancer data set Figures 1Aillustrates a plot of the Martingale residuals against the patient's age, with a Kernel smoother marked as the dashed line.Figure 1Bshows the Martingale residuals plotted against FIGO stage, with the median within each stage represented by...
To investigate the survival outcomes in patients with bulky stage IIIC and IV ovarian cancer, treated by primary debulking surgery (PDS) and selective use of neoadjuvant chemotherapy (NAC) according to institutional criteria. Medical records for advanced ovarian cancer patients who were treated at Nati...
This project is evaluating whether oral contraceptives and parity are as protective against ovarian cancer in BRCA1/2 carriers as they are for women in general. It is also determining whether there are survival differences between BRCA1/2 carriers with ovarian cancer compared to women with sporadic...
METHODS: A retrospective cohort study of consecutive patients with International Federation of Gynecology and Obstetrics stage IIIC ovarian cancer undergoing primary surgery was conducted between January 1, 1994, and December 31, 1998. The main outcome measures were residual disease after cytoreduction, ...
Surgery for platinum-sensitive, relapsed ovarian cancer (PSROC) is widely practiced but had contradictory survival outcomes in previous studies. In this multicenter, open-label, phase 3 trial, women with PSROC, and having had one previous therapy and no platinum-based chemotherapy (platinum-free...